Form 4: U.S. Physical Therapy Director Sells 2,000 Shares

Clayton Trier, a director at U.S. Physical Therapy Inc., sold 2,000 shares of common stock at an average price of $95.78.

Summary

• Clayton Trier, a director of U.S. Physical Therapy Inc., sold 2,000 shares of the company's common stock on November 8, 2024.
• The sale was executed at a weighted average price of $95.78 per share.
• The prices for the shares sold ranged from $95.15 to $96.84.
• Following the transaction, Trier beneficially owns 6,424 shares of U.S. Physical Therapy Inc.
• This total includes 712 shares of restricted stock that will vest in two tranches in 2025.

Sentiment

Score: 5

Explanation: The document is a neutral report of a stock sale by a director, with no indication of positive or negative sentiment.

Industry Context

This is a routine Form 4 filing, which is common for corporate insiders who trade company stock. It does not indicate any specific trend in the physical therapy industry.

Comparison to Industry Standards

• Form 4 filings are standard practice for publicly traded companies, and this transaction is consistent with typical insider trading activity.
• There are no specific industry benchmarks to compare this transaction to, as it is an individual director's sale of shares.

Stakeholder Impact

• The sale of shares by a director may have a minor impact on shareholder sentiment, but is unlikely to have a significant effect on the company's operations or other stakeholders.

Key Dates

Keywords

insider trading, stock sale, director, USPH, U.S. Physical Therapy Inc., common stock, equity